T40mg T40mg: Research Dual Incretin Agonist (GLP-1 / GIP Pathways) 1 GLP-TIRZ (10mg) Key Features Dual-pathway incretin research peptide (GLP-1R + GIPR) Lyophilized for stability and accurate laboratory handling QC verified for identity and batch consistency
That second hormone, GIP, adds extra metabolic benefits like better insulin response, more efficient fat burning, and increased energy use

Seek urgent medical help if you experience: severe or persistent abdominal pain , especially if it is intense, worsening, or not linked to meals upper abdominal pain that spreads to the back , with or without nausea or vomiting ongoing or uncontrollable vomiting that stops you from eating or drinking right-sided abdominal pain , particularly after meals signs of pancreatitis , such as severe stomach pain with vomiting and feeling very unwell signs of acute kidney injury , including very low urine output, dark urine, swelling in the legs or ankles, or extreme tiredness allergic reactions , such as swelling of the face, lips, tongue, or throat, difficulty breathing or swallowing, or a widespread rash sudden or worsening vision changes , including blurred vision, flashes of light, or sudden vision loss These symptoms, while uncommon, are not expected side effects and should not be managed at home
J., Rosenstock, J., et al
Tirzepatide that has been exposed to temperatures above 86F (30C), kept at room temperature for more than 21 days before use, frozen at any time, or kept past its expiration date should not be used regardless of appearance
Preservative systems The preservatives included in the formulation significantly impact shelf life